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Sir,
We read with interest the recent article indicating that a pre-
operative systemic inflammatory response is an underlying host
characteristic that predisposes to postoperative infection in
patients undergoing potentially curative resection for colorectal
cancer. In this article, the Glasgow group found that elevated
C-reactive protein together with low albumin levels (Glasgow pro-
gnostic score, GPS) were the only host-associated factors that had
a high predictive value, which included 40% of patients affected
by postoperative infectious complications (Moyes et al, 2009).
Postoperative infectious complications are usually classified into
surgical site infections (SSIs) and remote infections. An SSI as
represented by wound infection and anastomotic leak is an
infection that occurs after surgery in the part of the body where the
surgery occurred, and is further classified into incisional and
organ/space SSIs. In contrast, a remote infection as represented by
respiratory organ infection, infection via catheters, urinary tract
infection, and antibiotic enterocolitis, is an exogenous and/or cross
infection that occurs at sites not directly subjected to operations.
With regard to aetiological bacteria of these infections, the onset of
an SSI is usually caused by contaminants that exist in the operative
fields. The onset of a remote infection is often caused by antibiotic-
resistant bacteria that cause nosocomial infections, such as
Pseudomonas aeruginosa or methicillin-resistant Staphylococcus
aureus. Thus, SSIs and remote infections may have a distinct
pathogenesis, being specific to the different underlying mechan-
isms, and may differ from each other with respect to their risk
factors (Edwards, 1976). It is important to identify which clinical
and laboratory factors can predict site-specific patterns of
infectious complications in SSIs and remote infections, because
it may assist surgeons with specific strategies for prevention of
infection according to each patient’s risk factor. However, the
authors did not evaluate measurable preoperative clinical and
laboratory markers that may be able to predict site-specific
patterns of postoperative infectious complications in SSIs and
remote infections.
In our previous study, we determined site-specific patterns of
risk factors for incisional and organ/space SSIs in 285 colorectal
cancer patients to develop predictive models using inflammatory
mediators (Miki et al, 2006). We found that operating time and
concomitant medical problems were independently associated
with the development of incisional SSIs, whereas operating time,
tumour location, obesity and concomitant medical problems were
independently associated with the development of organ/space
SSIs. However, we were not able to distinguish clinical factors that
could predict remote infections from those that could predict SSIs
because of a limited number of patients. We would like to ask the
authors to show whether GPS can predict site-specific patterns
of postoperative infectious complications in SSIs and remote
infections. We believe that GPS could differentiate the odds of
developing SSI from the odds of developing remote infection,
because they could successfully sort out only one host-associated
factor from a large number of patients (n¼455) and the patients
with postoperative complications could be nearly equally divided
into an SSI group (n¼31) and a remote infection group (n¼39) If
the odds of developing rates of SSI and remote infection are
identified for each risk factor, then the GPS can be used by the
surgeon to determine whether he/she should correct host-
associated pathological states before surgery for preventing remote
infection, or select less invasive surgery for minimising adverse
effects of surgery-associated factors for preventing SSI. Although
prospective randomised studies are required to clarify whether
these suspected advantages can be realised in clinical practice,
colorectal surgeons need to select from the strategies mentioned
above for their cancer patients, if the GPS can differentiate the SSIs
from remote infections.
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